Artivion, Inc.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurol…
Insiders
Transactions
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
---|---|---|---|---|---|---|---|
$134,464
d
cs
10% Holder
|
12/12/24 |
G
|
1,100 x $0 = $0 |
Footnotes
#1 1,100 shares were gifted by the reporting person to a charity.
|
|||
$153,862
d
cs
10% Holder
|
12/11/24 |
S
|
4,035 x $30.00 = $121,050.00 |
Footnotes
#1 Reflects the price the shares were sold.
|
|||
$157,897
d
cs
10% Holder
|
12/11/24 |
S
|
4,035 x $30.25 = $122,058.75 |
Footnotes
#1 Reflects the price the shares were sold.
|
|||
$135,660
d
cs
10% Holder
|
12/06/24 |
S
|
4,329 x $29.66 = $128,398.14 |
Footnotes
#1 These shares were sold upon the vesting of Restricted Stock Units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
|
|||
$33,503
d
cs
10% Holder
|
12/04/24 |
S
|
7,618 x $30.00 = $228,540.00 |
Footnotes
#1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 13, 2024.
#2 Reflects the price the shares were sold.
|
Get PRO Today
With PRO you will unlock 110 more insider transactions for Artivion, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Ackerman Thomas F Director
- Berry Lance A Executive VP, CFO
- Bevevino Daniel J Director
- Borgstrom Marna P Director
- Bullock James Director
- Burbank Jeffrey H Director
- Davis John E Chief Commercial Officer
- Getz Matthew A VP, Human Resources
- Green Andrew M VP Regulatory
- Hoff Elizabeth A Director
- Holloway Jean F SVP, General Counsel
- Horton Amy VP, Chief Accounting Officer
- Mackin James P President & CEO
- Maney Rochelle L. VP, Quality
- Salveson Jon W Director
- Semedo Anthony B. Director
- Stanton Marshall S. SVP, Clinical & MD Affair
- Thomson Robert C VP Research & Development
- Tyrs Florian VP, Global Operations
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Ackerman Thomas F Director
- Berry Lance A Executive VP, CFO
- Bevevino Daniel J Director
- Borgstrom Marna P Director
- Bullock James Director
- Burbank Jeffrey H Director
- Davis John E Chief Commercial Officer
- Getz Matthew A VP, Human Resources
- Green Andrew M VP Regulatory
- Hoff Elizabeth A Director
- Holloway Jean F SVP, General Counsel
- Horton Amy VP, Chief Accounting Officer
- Mackin James P President & CEO
- Maney Rochelle L. VP, Quality
- Salveson Jon W Director
- Semedo Anthony B. Director
- Stanton Marshall S. SVP, Clinical & MD Affair
- Thomson Robert C VP Research & Development
- Tyrs Florian VP, Global Operations